{
  "meta": {
    "title": "Myelodysplastic_Syndromes",
    "url": "https://brainandscalpel.vercel.app/myelodysplastic-syndromes-2890bf94.html",
    "scrapedAt": "2025-11-30T18:54:07.760Z"
  },
  "questions": [
    {
      "text": "A previously healthy 75-year-old woman comes to the physician because of fatigue and decreasing exercise tolerance over the past 6 weeks. She also has intermittent episodes of dizziness. She has never smoked and does not drink alcohol. She takes a daily multivitamin. She appears pale. Physical examination shows a smooth liver that is palpable 1 cm below the costal margin. The spleen is not palpable. Laboratory studies show:\n\n\nHemoglobin\n9.8 g/dL\n\n\nMCV\n104 fL\n\n\nReticulocyte count\n0.2 %\n\n\nFolate\n21 ng/mL (N = 2–20)\n\n\nVitamin B12\n\n789 pg/mL (N = 200–900)\n\n\nA peripheral blood smear shows anisocytosis and bone marrow aspirate shows ringed sideroblasts. This patient is most likely to develop which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Sézary syndrome"
        },
        {
          "id": 2,
          "text": "Chronic lymphocytic leukemia"
        },
        {
          "id": 3,
          "text": "Diffuse large B-cell lymphoma"
        },
        {
          "id": 4,
          "text": "Acute myelocytic leukemia"
        },
        {
          "id": 5,
          "text": "Multiple myeloma"
        },
        {
          "id": 6,
          "text": "Hairy cell leukemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>A) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=oT0072&anker=Z62812d8eb06386505986efff8b5e43ac\" data-learningcard-id=\"oT0072\" data-anker=\"Z62812d8eb06386505986efff8b5e43ac\" data-section-id=\"o500Og\" data-sememe-id=\"UPbbVF\">Sézary syndrome</a> is a cutaneous <a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z46cc87b0bb6d0dccc4fedce8fd20de06\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z46cc87b0bb6d0dccc4fedce8fd20de06\" data-sememe-id=\"mP0V2T\">non-Hodgkin lymphoma</a> that can develop secondary to <a href=\"https://www.amboss.com/us/library#xid=oT0072&anker=Z395795b5f9f4dcc3b1c80ee43d8540c6\" data-learningcard-id=\"oT0072\" data-anker=\"Z395795b5f9f4dcc3b1c80ee43d8540c6\" data-sememe-id=\"LP0w2T\">mycosis fungoides</a>. Although <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a> can occur, other features such as <a href=\"https://www.amboss.com/us/library#xid=XL09wg&anker=Zc94d2bbee026f3c13b49fbe3bbeb1d97\" data-learningcard-id=\"XL09wg\" data-anker=\"Zc94d2bbee026f3c13b49fbe3bbeb1d97\" data-section-id=\"eccxYY0\" data-sememe-id=\"fmXkUA\">hepatosplenomegaly</a>, <a href=\"https://www.amboss.com/us/library#xid=iL0Jxg&anker=Z7b0bf382e960f8be4f9fccafce5ff227\" data-learningcard-id=\"iL0Jxg\" data-anker=\"Z7b0bf382e960f8be4f9fccafce5ff227\" data-section-id=\"2YWToP0\" data-sememe-id=\"66cjNW0\">generalized lymphadenopathy</a>, and <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemic</a> dissemination would also be expected. More importantly, because <a href=\"https://www.amboss.com/us/library#xid=oT0072&anker=Z395795b5f9f4dcc3b1c80ee43d8540c6\" data-learningcard-id=\"oT0072\" data-anker=\"Z395795b5f9f4dcc3b1c80ee43d8540c6\" data-sememe-id=\"LP0w2T\">mycosis fungoides</a> is a cutaneous <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z2586a20a2f640af294a4d86b9f8439d0\" data-learningcard-id=\"WM0Png\" data-anker=\"Z2586a20a2f640af294a4d86b9f8439d0\" data-section-id=\"azXQr00\" data-sememe-id=\"7RX4oB\">lymphoma</a>, these findings would be preceded by intensely pruritic <a href=\"https://www.amboss.com/us/library#xid=4k03LT&anker=Za45a91a80d364214542d6bc96b51f4a7\" data-learningcard-id=\"4k03LT\" data-anker=\"Za45a91a80d364214542d6bc96b51f4a7\" data-section-id=\"o0b0SH\" data-sememe-id=\"3UaS1P\">erythroderma</a> accompanied by <span data-sememe-id=\"3j0SZT\">palmar</span> and <span data-sememe-id=\"3j0SZT\">plantar</span> <a href=\"https://www.amboss.com/us/library#xid=_405NT&anker=Z2bc64defed862e7e4322371faccec009\" data-learningcard-id=\"_405NT\" data-anker=\"Z2bc64defed862e7e4322371faccec009\" data-section-id=\"ttcX2V0\" data-sememe-id=\"qT0C72\">hyperkeratosis</a>. Atypical <a href=\"https://www.amboss.com/us/library#xid=x50Emg&anker=Zb648e3ccdd39ac912f7d40f71b5d94c0\" data-learningcard-id=\"x50Emg\" data-anker=\"Zb648e3ccdd39ac912f7d40f71b5d94c0\" data-section-id=\"j_X_L00\" data-sememe-id=\"-MbDr8\">T cells</a> would be present on <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Zd341fc04d16d4edc4db07a6f5fd34293\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Zd341fc04d16d4edc4db07a6f5fd34293\" data-section-id=\"OU1IWT0\" data-sememe-id=\"qHbCrE\">peripheral blood smear</a> instead of <a href=\"https://www.amboss.com/us/library#xid=WS0PA2&anker=Zc75ab97c92a442d0abeb6229ddc9988a\" data-learningcard-id=\"WS0PA2\" data-anker=\"Zc75ab97c92a442d0abeb6229ddc9988a\" data-section-id=\"tJXXD_\" data-sememe-id=\"2I0TXh\">ringed sideroblasts</a>. <a href=\"https://www.amboss.com/us/library#xid=oT0072&anker=Z62812d8eb06386505986efff8b5e43ac\" data-learningcard-id=\"oT0072\" data-anker=\"Z62812d8eb06386505986efff8b5e43ac\" data-section-id=\"o500Og\" data-sememe-id=\"UPbbVF\">Sézary syndrome</a> is not associated with <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>.<img src='https://media-us.amboss.com/media/thumbs/big_5081d9531430a.jpg' alt='Explanation Image' style='width: 100%; border-radius: 12px; margin-top: 16px;'><div style='margin-top: 16px; border-top: 1px solid rgba(255,255,255,0.1); padding-top: 16px;'><h5 style='font-weight: bold; color: rgba(255,255,255,0.7); margin-bottom: 8px;'>Image Description:</h5><div style='font-size: 0.9em; color: rgba(255,255,255,0.9); line-height: 1.6;'><p>Left upper arm, shoulder, and back with sharply demarcated, partially confluent, erythematous scaling lesions that are severely pruritic.</p></div></div></div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>B) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=jT0_q2&anker=Z2864a45f3480a8418833d334d4601008\" data-learningcard-id=\"jT0_q2\" data-anker=\"Z2864a45f3480a8418833d334d4601008\" data-sememe-id=\"kP0mUT\">Chronic lymphocytic leukemia</a> (<a href=\"https://www.amboss.com/us/library#xid=jT0_q2&anker=Z2864a45f3480a8418833d334d4601008\" data-learningcard-id=\"jT0_q2\" data-anker=\"Z2864a45f3480a8418833d334d4601008\" data-sememe-id=\"kP0mUT\">CLL</a>) primarily occurs in older patients (&gt; 70 years) and could explain this patient's <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a>. However, <a href=\"https://www.amboss.com/us/library#xid=jT0_q2&anker=Z2864a45f3480a8418833d334d4601008\" data-learningcard-id=\"jT0_q2\" data-anker=\"Z2864a45f3480a8418833d334d4601008\" data-sememe-id=\"kP0mUT\">CLL</a> more commonly manifests with a more insidious onset of <a href=\"https://www.amboss.com/us/library#xid=mT0Vr2&anker=Zfb6f18bd1a90e6210c6c195344e22cb0\" data-learningcard-id=\"mT0Vr2\" data-anker=\"Zfb6f18bd1a90e6210c6c195344e22cb0\" data-section-id=\"6m0jgg\" data-sememe-id=\"tI0Xeh\">B symptoms</a>, <a href=\"https://www.amboss.com/us/library#xid=XL09wg&anker=Zc94d2bbee026f3c13b49fbe3bbeb1d97\" data-learningcard-id=\"XL09wg\" data-anker=\"Zc94d2bbee026f3c13b49fbe3bbeb1d97\" data-section-id=\"eccxYY0\" data-sememe-id=\"fmXkUA\">hepatosplenomegaly</a>, and painless <a href=\"https://www.amboss.com/us/library#xid=iL0Jxg&anker=Z9a24d08ab67dee43098222189f24cc1a\" data-learningcard-id=\"iL0Jxg\" data-anker=\"Z9a24d08ab67dee43098222189f24cc1a\" data-sememe-id=\"OCYIHr\">lymphadenopathy</a> and is not associated with <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>. Predisposing factors include positive <a href=\"https://www.amboss.com/us/library#xid=En08Eg&anker=Z0ccd21fcf57fab20ffb12c037f4d9af3\" data-learningcard-id=\"En08Eg\" data-anker=\"Z0ccd21fcf57fab20ffb12c037f4d9af3\" data-section-id=\"ol10BS0\">family history</a>, advanced age, and exposure to organic solvents. <span data-sememe-id=\"rdbfrs\">Bone marrow biopsy</span> of patients with <a href=\"https://www.amboss.com/us/library#xid=jT0_q2&anker=Z2864a45f3480a8418833d334d4601008\" data-learningcard-id=\"jT0_q2\" data-anker=\"Z2864a45f3480a8418833d334d4601008\" data-sememe-id=\"kP0mUT\">CLL</a> would reveal <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z52ee70f22757427a78044a881188550e\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z52ee70f22757427a78044a881188550e\" data-section-id=\"OU1IWT0\" data-sememe-id=\"AMbRr8\">lymphocytosis</a> and characteristic <a href=\"https://www.amboss.com/us/library#xid=jT0_q2&anker=Ze729800477da45ef39451d892073e846\" data-learningcard-id=\"jT0_q2\" data-anker=\"Ze729800477da45ef39451d892073e846\" data-section-id=\"dN0oZg\" data-sememe-id=\"PI0W1h\">smudge cells</a> rather than <a href=\"https://www.amboss.com/us/library#xid=WS0PA2&anker=Zc75ab97c92a442d0abeb6229ddc9988a\" data-learningcard-id=\"WS0PA2\" data-anker=\"Zc75ab97c92a442d0abeb6229ddc9988a\" data-section-id=\"tJXXD_\" data-sememe-id=\"2I0TXh\">ringed sideroblasts</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>C) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z79bcf9d1766d32c187d9abad183b79b7\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z79bcf9d1766d32c187d9abad183b79b7\" data-section-id=\"F4cgOc0\" data-sememe-id=\"MvbM0D\">Diffuse large B-cell lymphoma</a> (<a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z79bcf9d1766d32c187d9abad183b79b7\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z79bcf9d1766d32c187d9abad183b79b7\" data-section-id=\"F4cgOc0\" data-sememe-id=\"MvbM0D\">DLBCL</a>), the most common <a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z46cc87b0bb6d0dccc4fedce8fd20de06\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z46cc87b0bb6d0dccc4fedce8fd20de06\" data-sememe-id=\"mP0V2T\">non-Hodgkin lymphoma</a> in adults, can occur spontaneously or secondary to numerous low-grade <a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Zb49c95882608f7281f137678360b7255\" data-learningcard-id=\"NT0-I2\" data-anker=\"Zb49c95882608f7281f137678360b7255\" data-section-id=\"F4cgOc0\">B-cell lymphomas</a> (e.g., <a href=\"https://www.amboss.com/us/library#xid=jT0_q2&anker=Z2864a45f3480a8418833d334d4601008\" data-learningcard-id=\"jT0_q2\" data-anker=\"Z2864a45f3480a8418833d334d4601008\" data-sememe-id=\"kP0mUT\">chronic lymphocytic leukemia</a>). Patients with <a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z79bcf9d1766d32c187d9abad183b79b7\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z79bcf9d1766d32c187d9abad183b79b7\" data-section-id=\"F4cgOc0\" data-sememe-id=\"MvbM0D\">DLBCL</a> are of advanced age (&gt; 70 years) and present with a rapidly enlarging mass within the <a href=\"https://www.amboss.com/us/library#xid=960NMS&anker=Z1e7315a31bc800e90ec22cdf81497c3b\" data-learningcard-id=\"960NMS\" data-anker=\"Z1e7315a31bc800e90ec22cdf81497c3b\" data-section-id=\"0Ece8V0\" data-sememe-id=\"5oXic_\">lymph</a> system. However, <a href=\"https://www.amboss.com/us/library#xid=mT0Vr2&anker=Zfb6f18bd1a90e6210c6c195344e22cb0\" data-learningcard-id=\"mT0Vr2\" data-anker=\"Zfb6f18bd1a90e6210c6c195344e22cb0\" data-section-id=\"6m0jgg\" data-sememe-id=\"tI0Xeh\">B symptoms</a> (weight loss, <a href=\"https://www.amboss.com/us/library#xid=j50_Pg&anker=Za5de83449ff6a749e6c1348b93b1f3b1\" data-learningcard-id=\"j50_Pg\" data-anker=\"Za5de83449ff6a749e6c1348b93b1f3b1\" data-sememe-id=\"CL0q-g\">fever</a>, night sweats) and painless <a href=\"https://www.amboss.com/us/library#xid=iL0Jxg&anker=Z9a24d08ab67dee43098222189f24cc1a\" data-learningcard-id=\"iL0Jxg\" data-anker=\"Z9a24d08ab67dee43098222189f24cc1a\" data-sememe-id=\"OCYIHr\">lymphadenopathy</a> would also be expected. In addition, <a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z79bcf9d1766d32c187d9abad183b79b7\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z79bcf9d1766d32c187d9abad183b79b7\" data-section-id=\"F4cgOc0\" data-sememe-id=\"MvbM0D\">DLBCL</a> would not cause <a href=\"https://www.amboss.com/us/library#xid=WS0PA2&anker=Zc75ab97c92a442d0abeb6229ddc9988a\" data-learningcard-id=\"WS0PA2\" data-anker=\"Zc75ab97c92a442d0abeb6229ddc9988a\" data-section-id=\"tJXXD_\" data-sememe-id=\"2I0TXh\">ringed sideroblasts</a> and does not occur in association with <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a>.</div><div><h4 style='color: #34d399; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>D) CORRECT:</h4>\n<span class=\"wichtig\"><b><a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">Acute myelocytic leukemia</a></b></span> (<a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">AML</a>) develops in up to 30% of patients with <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>. The two conditions are distinguished based on the <span class=\"wichtig\"><b>blast percentage in the <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zba672ce639f8a71189c3b29114401a54\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zba672ce639f8a71189c3b29114401a54\" data-section-id=\"NDc-ee0\" data-sememe-id=\"CYcqra0\">bone marrow</a></b></span> (blast percentage &gt; 20% in <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">AML</a>) and the presence of <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">AML</a>-related <a href=\"https://www.amboss.com/us/library#xid=e40xRT&anker=Zf4a861e8ee2973aceb14c60d93b4d6d0\" data-learningcard-id=\"e40xRT\" data-anker=\"Zf4a861e8ee2973aceb14c60d93b4d6d0\">chromosomal abnormalities</a> in <a href=\"https://www.amboss.com/us/library#xid=uo0pdS&anker=Z3f0f39f7aa77cb2381c6036f2f404265\" data-learningcard-id=\"uo0pdS\" data-anker=\"Z3f0f39f7aa77cb2381c6036f2f404265\" data-section-id=\"zKcrQW0\" data-sememe-id=\"1xb2vD\">pluripotent</a> <a href=\"https://www.amboss.com/us/library#xid=uo0pdS&anker=Z84c49626f7daebca811b981e8045a644\" data-learningcard-id=\"uo0pdS\" data-anker=\"Z84c49626f7daebca811b981e8045a644\" data-section-id=\"zKcrQW0\">stem cells</a>. Patients with <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> that progresses to <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">AML</a> have a worse prognosis because they are not as responsive to <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Z4c7ae79c18cb3c2f3e1fa98185b2d78d\" data-learningcard-id=\"4m03fg\" data-anker=\"Z4c7ae79c18cb3c2f3e1fa98185b2d78d\" data-sememe-id=\"ifbJNG\">chemotherapy</a> (compared to patients with de novo <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">AML</a>).<br>\n<img src='https://media-us.amboss.com/media/thumbs/big_59a8334ca8655.jpg' alt='Explanation Image' style='width: 100%; border-radius: 12px; margin-top: 16px;'><div style='margin-top: 16px; border-top: 1px solid rgba(255,255,255,0.1); padding-top: 16px;'><h5 style='font-weight: bold; color: rgba(255,255,255,0.7); margin-bottom: 8px;'>Image Description:</h5><div style='font-size: 0.9em; color: rgba(255,255,255,0.9); line-height: 1.6;'><p>Photomicrograph of a peripheral blood smear (Pappenheim stain)</p><p>This specimen depicts anisocytosis, which are erythrocytes of different sizes (black circles), as well as poikilocytosis, which are erythrocytes of different shapes. Acanthocytes with thorny projections (light blue circles) and teardrop shaped dacrocytes (red circles) are present.</p><p>These findings suggest impaired erythropoiesis, which may be a result of impaired bone marrow hematopoiesis.</p></div></div></div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>E) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=5T0ir2&anker=Z5fb268006e2c847ae772c92665e035a1\" data-learningcard-id=\"5T0ir2\" data-anker=\"Z5fb268006e2c847ae772c92665e035a1\" data-sememe-id=\"MP0M2T\">Multiple myeloma</a> (MM) can develop secondary to <a href=\"https://www.amboss.com/us/library#xid=5T0ir2&anker=Z8a2da64963665dfe0b91850162d6b953\" data-learningcard-id=\"5T0ir2\" data-anker=\"Z8a2da64963665dfe0b91850162d6b953\" data-section-id=\"_m05Rg\" data-sememe-id=\"Xr09fh\">monoclonal gammopathy of undetermined significance</a> (<a href=\"https://www.amboss.com/us/library#xid=5T0ir2&anker=Z8a2da64963665dfe0b91850162d6b953\" data-learningcard-id=\"5T0ir2\" data-anker=\"Z8a2da64963665dfe0b91850162d6b953\" data-section-id=\"_m05Rg\" data-sememe-id=\"Xr09fh\">MGUS</a>), which is diagnosed in asymptomatic patients with elevated serum monoclonal <a href=\"https://www.amboss.com/us/library#xid=x50Emg&anker=Zcafc1c81671c54115ab5d77c08d696a0\" data-learningcard-id=\"x50Emg\" data-anker=\"Zcafc1c81671c54115ab5d77c08d696a0\" data-section-id=\"R_XlL00\" data-sememe-id=\"1fY2Oo\">immunoglobulins</a> (&gt;3 g/dL). Approximately 1% of patients with <a href=\"https://www.amboss.com/us/library#xid=5T0ir2&anker=Z8a2da64963665dfe0b91850162d6b953\" data-learningcard-id=\"5T0ir2\" data-anker=\"Z8a2da64963665dfe0b91850162d6b953\" data-section-id=\"_m05Rg\" data-sememe-id=\"Xr09fh\">MGUS</a> progress to MM annually. <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">Anemia</a> could be an early sign of MM. However, other findings, such as bone <a href=\"https://www.amboss.com/us/library#xid=xN0EWg&anker=Zd673a3f7ee36023aab5a267899e984cc\" data-learningcard-id=\"xN0EWg\" data-anker=\"Zd673a3f7ee36023aab5a267899e984cc\" data-section-id=\"NBX-a00\">pain</a>, <a href=\"https://www.amboss.com/us/library#xid=UI0bXh&anker=Z41d268ef23bd72a995c6640c29f5c2c0\" data-learningcard-id=\"UI0bXh\" data-anker=\"Z41d268ef23bd72a995c6640c29f5c2c0\" data-section-id=\"lR1vMg0\">symptoms of hypercalcemia</a>, and foamy urine, would also be expected.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>F) INCORRECT:</h4>Although <a href=\"https://www.amboss.com/us/library#xid=NT0-I2&anker=Z0a7991355887d49a365293ad91d5f992\" data-learningcard-id=\"NT0-I2\" data-anker=\"Z0a7991355887d49a365293ad91d5f992\" data-section-id=\"F4cgOc0\" data-sememe-id=\"rI0fVh\">hairy cell leukemia</a> (HCL) could be responsible for this woman's <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a>, patients with HCL usually also have <a href=\"https://www.amboss.com/us/library#xid=KT0U72&anker=Zb4b68e804d844783408c64bd8c61b63f\" data-learningcard-id=\"KT0U72\" data-anker=\"Zb4b68e804d844783408c64bd8c61b63f\" data-section-id=\"XJX9s_\">massive splenomegaly</a>, as well as <a href=\"https://www.amboss.com/us/library#xid=wT0hG2&anker=Zdab14a350ac311c7a2589ab7d48358ad\" data-learningcard-id=\"wT0hG2\" data-anker=\"Zdab14a350ac311c7a2589ab7d48358ad\" data-sememe-id=\"sP0tTT\">thrombocytopenia</a> and <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z772ef39ffb5b26ae57fce3aa721f12a9\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z772ef39ffb5b26ae57fce3aa721f12a9\" data-section-id=\"OU1IWT0\" data-sememe-id=\"wMbhI8\">neutropenia</a> (multiple cells lines are affected). HCL is associated with exposure to <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Zc4389e9049b53cade58fa5f794deed44\" data-learningcard-id=\"WM0Png\" data-anker=\"Zc4389e9049b53cade58fa5f794deed44\" data-section-id=\"YzXnr00\" data-sememe-id=\"_dX5sC\">ionizing radiation</a> and pesticides, but not with <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a>.</div>",
      "hint": "This patient's symptomatic macrocytic anemia (low hemoglobin, high MCV) with an insufficient reticulocyte response indicates dysplastic hematopoiesis. Her normal folate and vitamin B12 levels indicate refractory anemia. Together with the presence of ringed sideroblasts, the laboratory results raise concern for myelodysplastic syndrome (MDS).",
      "explanations": [],
      "difficulty": "5/5",
      "question_id": "vt0A23",
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "A 75-year-old previously healthy man complains of slowly progressive fatigue and exercise intolerance during the past 6 months. He has not noticed any bleeding.\nOn examination, his vital signs are normal apart from a regular heart rate of 115 beats per minute. He appears fatigued and pale. His lung and abdominal exams are unremarkable. He has trace ankle edema. There are no petechiae or ecchymoses.\nLaboratory testing reveals the following results:\n\n\n\nPatient value\nReference range\n\n\nLeukocyte count (per mm3)\n4000\n4500–11,000\n\n\nNeutrophils (per mm3)\n1500\n1900–7600\n\n\n\nHemoglobin (g/dL)\n7.5\n13.5–17.5\n\n\nMean corpuscular volume (μm3)\n106\n80–100\n\n\nPlatelet count (per mm3)\n460,000\n150,000–350,000\n\n\nTotal bilirubin (mg/dL)\n0.5\n0.3–1.0\n\n\nCreatinine (mg/dL)\n0.4\n0.8–1.3\n\n\nFurther laboratory workup for blood loss, hemolysis, and nutrient deficiency is unremarkable. A bone-marrow aspirate and biopsy are consistent with a myelodysplastic syndrome.\nCytogenetics shows a deletion of chromosome 5q, consistent with a diagnosis of the 5q minus syndrome subtype of myelodysplastic syndrome.\nIn addition to transfusion support, which one of the following treatments is the most appropriate initial treatment for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Allogeneic hematopoietic stem-cell transplant"
        },
        {
          "id": 2,
          "text": "Decitabine"
        },
        {
          "id": 3,
          "text": "Azacitidine"
        },
        {
          "id": 4,
          "text": "Induction chemotherapy"
        },
        {
          "id": 5,
          "text": "Lenalidomide"
        }
      ],
      "correct_choice_id": 5,
      "solution": "<div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>A) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=TH06ph&anker=Z34f477e53deaa19e987c6934d37cbd25\" data-learningcard-id=\"TH06ph\" data-anker=\"Z34f477e53deaa19e987c6934d37cbd25\" data-section-id=\"l1WvS40\" data-sememe-id=\"zCWrun0\">Induction chemotherapy</a> and allogeneic <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zaf3eea93f4a62b1b114e6d818763b6ea\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zaf3eea93f4a62b1b114e6d818763b6ea\" data-section-id=\"NDc-ee0\" data-sememe-id=\"6i0jsf\">hematopoietic</a> stem-cell transplant are not indicated for lower-risk <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> patients.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>B) INCORRECT:</h4>Azacitidine and decitabine are <span data-sememe-id=\"lDWven0\">hypomethylating agents</span> that could also be considered. However, these agents have a higher risk-benefit <a href=\"https://www.amboss.com/us/library#xid=1j02zf&anker=Z72a88ef1b247b4893b9663b3737e8506\" data-learningcard-id=\"1j02zf\" data-anker=\"Z72a88ef1b247b4893b9663b3737e8506\" data-section-id=\"0GXeBz\" data-sememe-id=\"XAb9Rw\">ratio</a> in patients with low-risk disease. They are also generally reserved for patients with higher-risk <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndromes</a> or lower-risk patients who cannot tolerate, respond poorly to, or relapse on prior therapies.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>C) INCORRECT:</h4>Azacitidine and decitabine are <span data-sememe-id=\"lDWven0\">hypomethylating agents</span> that could also be considered. However, these agents have a higher risk-benefit <a href=\"https://www.amboss.com/us/library#xid=1j02zf&anker=Z72a88ef1b247b4893b9663b3737e8506\" data-learningcard-id=\"1j02zf\" data-anker=\"Z72a88ef1b247b4893b9663b3737e8506\" data-section-id=\"0GXeBz\" data-sememe-id=\"XAb9Rw\">ratio</a> in patients with low-risk disease. They are also generally reserved for patients with higher-risk <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndromes</a> or lower-risk patients who cannot tolerate, respond poorly to, or relapse on prior therapies.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>D) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=TH06ph&anker=Z34f477e53deaa19e987c6934d37cbd25\" data-learningcard-id=\"TH06ph\" data-anker=\"Z34f477e53deaa19e987c6934d37cbd25\" data-section-id=\"l1WvS40\" data-sememe-id=\"zCWrun0\">Induction chemotherapy</a> and allogeneic <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zaf3eea93f4a62b1b114e6d818763b6ea\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zaf3eea93f4a62b1b114e6d818763b6ea\" data-section-id=\"NDc-ee0\" data-sememe-id=\"6i0jsf\">hematopoietic</a> stem-cell transplant are not indicated for lower-risk <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> patients.</div><div><h4 style='color: #34d399; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>E) CORRECT:</h4>The 5q minus subtype of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> (<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>) is characterized by chronic <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusion</a>-dependent <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a>, which can lead to <span data-sememe-id=\"hrbcSE\">iron overload</span>. The characteristic <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z104e70d0abf334234d6d1c24c660d384\" data-learningcard-id=\"y50d5g\" data-anker=\"Z104e70d0abf334234d6d1c24c660d384\" data-section-id=\"xWcEnY0\" data-sememe-id=\"T0c62a0\">chromosome</a> abnormality is an <a href=\"https://www.amboss.com/us/library#xid=ro0fWS&anker=Zb2983e2120b77c2e29e4bd5c641f9550\" data-learningcard-id=\"ro0fWS\" data-anker=\"Zb2983e2120b77c2e29e4bd5c641f9550\" data-section-id=\"LocwcW0\" data-sememe-id=\"6LXjAA\">interstitial</a> deletion involving the long arm of <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z104e70d0abf334234d6d1c24c660d384\" data-learningcard-id=\"y50d5g\" data-anker=\"Z104e70d0abf334234d6d1c24c660d384\" data-section-id=\"xWcEnY0\" data-sememe-id=\"T0c62a0\">chromosome</a> 5 (usually 5q31q33). An elevated <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z6a213d06936d306b80f821bdab012e04\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z6a213d06936d306b80f821bdab012e04\" data-section-id=\"OU1IWT0\" data-sememe-id=\"e70xkh\">platelet count</a> can be a clue to this subtype of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> in some patients. <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z772ef39ffb5b26ae57fce3aa721f12a9\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z772ef39ffb5b26ae57fce3aa721f12a9\" data-section-id=\"OU1IWT0\" data-sememe-id=\"wMbhI8\">Neutropenia</a> or <a href=\"https://www.amboss.com/us/library#xid=wT0hG2&anker=Zdab14a350ac311c7a2589ab7d48358ad\" data-learningcard-id=\"wT0hG2\" data-anker=\"Zdab14a350ac311c7a2589ab7d48358ad\" data-sememe-id=\"sP0tTT\">thrombocytopenia</a> is rare, and the risk for progression to <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a> is low.<br><br><span data-sememe-id=\"jLb_x8\">Lenalidomide</span> is the most appropriate first-line treatment for the 5q minus syndrome. About two-thirds of affected patients achieve <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusion</a> independence, and about half have a complete cytogenetic response.<br><br><span class=\"wichtig\"><b>Key learning point:</b></span> The first-line treatment for the 5q minus subtype of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> is <span data-sememe-id=\"jLb_x8\">lenalidomide</span>.</div>",
      "hint": "",
      "explanations": [],
      "difficulty": "4/5",
      "question_id": "WgYP8o",
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "A 70-year-old woman presents with slowly progressive fatigue and dyspnea. Her medical history is significant for breast cancer that was diagnosed 5 years ago and treated with lumpectomy followed by adjuvant radiotherapy and chemotherapy with doxorubicin-cyclophosphamide. Her only current medication is anastrozole. She is otherwise asymptomatic and is in no distress.\nOther than a heart rate of 110 beats per minute, her vital signs are normal. She is pale. Cardiac examination is notable for a sinus tachycardia and systolic flow murmur. Lung and abdominal examinations are unremarkable. She has scattered ecchymoses and bilateral lower-extremity petechiae.\nHer laboratory results are as follows:\n\n\n\nPatient value\nReference range\n\n\nLeukocyte count (per mm3)\n3000\n4500–11,000\n\n\nNeutrophils (per mm3)\n1000\n1900–7600\n\n\nHemoglobin (g/dL)\n7.0\n12.0–16.0\n\n\nMean corpuscular volume (μm3)\n105\n80–100\n\n\nPlatelet count (per mm3)\n20,000\n150,000–350,000\n\n\nReticulocytes appear to be absent, and neutrophils have an abnormal morphology characterized by hypolobated and hypogranular forms.\nResults of a comprehensive metabolic panel, liver function tests, iron panel, vitamin B12 level, folate level, and serum protein electrophoresis are normal.\nWhich one of the following diagnoses is most likely in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Myelodysplastic syndrome"
        },
        {
          "id": 2,
          "text": "Myelofibrosis"
        },
        {
          "id": 3,
          "text": "Aplastic anemia"
        },
        {
          "id": 4,
          "text": "Pernicious anemia"
        },
        {
          "id": 5,
          "text": "Metastatic breast cancer"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><h4 style='color: #34d399; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>A) CORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">Pancytopenia</a> is indicative of bone-marrow failure. The most typical causes of bone-marrow failure include <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a>, <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemia</a>, <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Z662f3d972a21d72555c5912a02f7b769\" data-learningcard-id=\"DF0143\" data-anker=\"Z662f3d972a21d72555c5912a02f7b769\" data-section-id=\"iQdJDp0\" data-sememe-id=\"Sr0ygh\">aplastic anemia</a>, and immune-mediated effects of immune diseases, such as <a href=\"https://www.amboss.com/us/library#xid=dT0op2&anker=Zc038efa4f85b330e4a8d1d0224d5f1a9\" data-learningcard-id=\"dT0op2\" data-anker=\"Zc038efa4f85b330e4a8d1d0224d5f1a9\" data-sememe-id=\"6q0jzS\">systemic lupus erythematosus</a>.<br><br>The patient in this scenario most likely has therapy-related <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> (t-<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>), given the findings of <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a> with <a href=\"https://www.amboss.com/us/library#xid=WS0PA2&anker=Z838c13b8aa97e2d988ef4495460f2e0e\" data-learningcard-id=\"WS0PA2\" data-anker=\"Z838c13b8aa97e2d988ef4495460f2e0e\" data-section-id=\"tJXXD_\" data-sememe-id=\"-jbD1F\">macrocytosis</a>, absent <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7055a50505776dfcca4447ebfa50fa74\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7055a50505776dfcca4447ebfa50fa74\" data-section-id=\"macVOa0\" data-sememe-id=\"EP18gS0\">reticulocytes</a>, and abnormal <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zd36074c54a3f63afa3afea2a3d7d26db\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zd36074c54a3f63afa3afea2a3d7d26db\" data-section-id=\"nac7Oa0\" data-sememe-id=\"DMb1I8\">neutrophil</a> morphology. T-<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> and therapy-related <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a> classically develop 5 to 7 years after treatment with alkylating <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Z4c7ae79c18cb3c2f3e1fa98185b2d78d\" data-learningcard-id=\"4m03fg\" data-anker=\"Z4c7ae79c18cb3c2f3e1fa98185b2d78d\" data-sememe-id=\"ifbJNG\">chemotherapy agents</a> and <a href=\"https://www.amboss.com/us/library#xid=L50wkg&anker=Zd120147b0e92bb22668d9e60dfbdc88b\" data-learningcard-id=\"L50wkg\" data-anker=\"Zd120147b0e92bb22668d9e60dfbdc88b\" data-sememe-id=\"-L0DZS\">radiotherapy</a>. The use of <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Zaf1779dab451b9a98d11834d04e33388\" data-learningcard-id=\"4m03fg\" data-anker=\"Zaf1779dab451b9a98d11834d04e33388\" data-section-id=\"kW1mlf0\" data-sememe-id=\"4ka3Lk\">topoisomerase inhibitors</a> (such as <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Z755638f42b12fb67ef41212a511c5970\" data-learningcard-id=\"4m03fg\" data-anker=\"Z755638f42b12fb67ef41212a511c5970\" data-section-id=\"NW1-lf0\" data-sememe-id=\"OkaILk\">doxorubicin</a>) can lead to <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemia</a> occurring even earlier after treatment. Therapy related myeloid <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Za6c03f509be1b3d9dfdc8402fad24824\" data-learningcard-id=\"WM0Png\" data-anker=\"Za6c03f509be1b3d9dfdc8402fad24824\" data-section-id=\"azXQr00\" data-sememe-id=\"kXcmya0\">neoplasms</a> from <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Zb2e2f957b1930d98bb98637139b5a418\" data-learningcard-id=\"4m03fg\" data-anker=\"Zb2e2f957b1930d98bb98637139b5a418\" data-section-id=\"4W13lf0\" data-sememe-id=\"WkaP5k\">alkylating agents</a> and <a href=\"https://www.amboss.com/us/library#xid=L50wkg&anker=Zd120147b0e92bb22668d9e60dfbdc88b\" data-learningcard-id=\"L50wkg\" data-anker=\"Zd120147b0e92bb22668d9e60dfbdc88b\" data-sememe-id=\"-L0DZS\">radiotherapy</a> is often characterized by abnormalities affecting <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z104e70d0abf334234d6d1c24c660d384\" data-learningcard-id=\"y50d5g\" data-anker=\"Z104e70d0abf334234d6d1c24c660d384\" data-section-id=\"xWcEnY0\" data-sememe-id=\"T0c62a0\">chromosomes</a> 5 and 7; those occurring after <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Zaf1779dab451b9a98d11834d04e33388\" data-learningcard-id=\"4m03fg\" data-anker=\"Zaf1779dab451b9a98d11834d04e33388\" data-section-id=\"kW1mlf0\" data-sememe-id=\"4ka3Lk\">topoisomerase inhibitor</a> therapy often have <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z7b39e2aeed109f898990c9b2e0d1d777\" data-learningcard-id=\"y50d5g\" data-anker=\"Z7b39e2aeed109f898990c9b2e0d1d777\" data-section-id=\"BWcznY0\" data-sememe-id=\"UfYblo\">balanced translocations</a> involving <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z104e70d0abf334234d6d1c24c660d384\" data-learningcard-id=\"y50d5g\" data-anker=\"Z104e70d0abf334234d6d1c24c660d384\" data-section-id=\"xWcEnY0\" data-sememe-id=\"T0c62a0\">chromosome</a> 11q23. Patients often present with progressive <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a> and <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplastic</a> morphology of blood cells before progressing to <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>, but they can also develop therapy-related <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a> without antecedent <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>. The prognosis for patients with t-<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> is poor.<br><br><span class=\"wichtig\"><b>Key learning point:</b></span> The most likely diagnosis in a patient who presents with bone-marrow failure 5 years after receiving <a href=\"https://www.amboss.com/us/library#xid=4m03fg&anker=Z4c7ae79c18cb3c2f3e1fa98185b2d78d\" data-learningcard-id=\"4m03fg\" data-anker=\"Z4c7ae79c18cb3c2f3e1fa98185b2d78d\" data-sememe-id=\"ifbJNG\">chemotherapy</a> and <a href=\"https://www.amboss.com/us/library#xid=L50wkg&anker=Zd120147b0e92bb22668d9e60dfbdc88b\" data-learningcard-id=\"L50wkg\" data-anker=\"Zd120147b0e92bb22668d9e60dfbdc88b\" data-sememe-id=\"-L0DZS\">radiotherapy</a> for <a href=\"https://www.amboss.com/us/library#xid=_k05qT&anker=Z3186a2e5e91124c9021effe4344433c7\" data-learningcard-id=\"_k05qT\" data-anker=\"Z3186a2e5e91124c9021effe4344433c7\" data-sememe-id=\"4M03Kg\">breast cancer</a> is therapy-related <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>B) INCORRECT:</h4>Unlike myelodysplasia, <a href=\"https://www.amboss.com/us/library#xid=lT0vI2&anker=Z9af0c56b193fde326cb2a88e64107b81\" data-learningcard-id=\"lT0vI2\" data-anker=\"Z9af0c56b193fde326cb2a88e64107b81\" data-section-id=\"YJXns_\" data-sememe-id=\"soatWl\">myelofibrosis</a> is typically associated with <a href=\"https://www.amboss.com/us/library#xid=KT0U72&anker=Z755ac88bb64f9363cd02e1d26ffc61a4\" data-learningcard-id=\"KT0U72\" data-anker=\"Z755ac88bb64f9363cd02e1d26ffc61a4\" data-sememe-id=\"oP00fT\">splenomegaly</a> and <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z935f11d569819a901970af4c6c1548a3\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z935f11d569819a901970af4c6c1548a3\" data-section-id=\"OU1IWT0\" data-sememe-id=\"vZcAWa0\">leukoerythroblastosis</a> with a low-grade <span data-sememe-id=\"qycCTU0\">reticulocytosis</span>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>C) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Z662f3d972a21d72555c5912a02f7b769\" data-learningcard-id=\"DF0143\" data-anker=\"Z662f3d972a21d72555c5912a02f7b769\" data-section-id=\"iQdJDp0\" data-sememe-id=\"Sr0ygh\">Aplastic anemia</a> can resemble <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> in that it can cause <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a> and <a href=\"https://www.amboss.com/us/library#xid=WS0PA2&anker=Z838c13b8aa97e2d988ef4495460f2e0e\" data-learningcard-id=\"WS0PA2\" data-anker=\"Z838c13b8aa97e2d988ef4495460f2e0e\" data-section-id=\"tJXXD_\" data-sememe-id=\"-jbD1F\">macrocytosis</a>. However, the morphologic changes in the <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z18a02873023ccef6d8ea2b461e0b7446\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z18a02873023ccef6d8ea2b461e0b7446\" data-section-id=\"5aciOa0\" data-sememe-id=\"86bO5u\">leukocytes</a> in this patient reflect a maturation defect, and the history of cancer treatment makes one lean toward <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> as the cause. The definitive way to distinguish these entities is to perform a <span data-sememe-id=\"rdbfrs\">bone marrow biopsy</span>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>D) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=6R0jLf&anker=Z23d6b596faa18f57dcb166c93439d25e\" data-learningcard-id=\"6R0jLf\" data-anker=\"Z23d6b596faa18f57dcb166c93439d25e\" data-section-id=\"wHahsN\" data-sememe-id=\"6ZajcQ\">Pernicious anemia</a> is unlikely in a patient with a normal <a href=\"https://www.amboss.com/us/library#xid=Ao0ReS&anker=Z938e3f87e91ee8469e94c3ace50e692d\" data-learningcard-id=\"Ao0ReS\" data-anker=\"Z938e3f87e91ee8469e94c3ace50e692d\" data-section-id=\"MpcMJW0\" data-sememe-id=\"oZa0cQ\">vitamin B<sub>12</sub></a> level.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>E) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z56ce78424b29da57669d773285a33fa6\" data-learningcard-id=\"WM0Png\" data-anker=\"Z56ce78424b29da57669d773285a33fa6\" data-section-id=\"XzX9r00\" data-sememe-id=\"IrXYiz\">Metastatic</a> <a href=\"https://www.amboss.com/us/library#xid=_k05qT&anker=Z3186a2e5e91124c9021effe4344433c7\" data-learningcard-id=\"_k05qT\" data-anker=\"Z3186a2e5e91124c9021effe4344433c7\" data-sememe-id=\"4M03Kg\">breast cancer</a> is unlikely to cause <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a>, because the extensive bony replacement necessary to produce a <span data-sememe-id=\"n307Qf\">myelophthisic anemia</span> would usually include bone symptoms before <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a> develops.</div>",
      "hint": "",
      "explanations": [],
      "difficulty": "3/5",
      "question_id": "dgYo8o",
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "A 75-year-old man reports a 4-month history of progressively worsening dyspnea, fatigue, and exercise intolerance. One week ago, he noticed unexplained bruising and had two episodes of epistaxis. He has smoked one pack of cigarettes daily for 55 years.\nOn examination, the patient is afebrile, in no distress, and appears pale and tired. His heart rate is 105 beats per minute, his blood pressure is 110/70 mm Hg, and his respiratory rate is 18 breaths per minute. He has normal oxygen saturation, his heartbeat is regular and tachycardic, and his lungs are clear. His abdomen is soft without hepatosplenomegaly. He has several ecchymoses on his extremities and a petechial rash on his lower extremities, but no edema.\nLaboratory testing reveals these results:\n\n\n\nPatient value\nReference range\n\n\nLeukocyte count (per mm3)\n2200\n4500–11,000\n\n\nNeutrophils (per mm3)\n1000\n1900–7600\n\n\nMonocytes (per mm3)\n500\n100–800\n\n\nHemoglobin (g/dL)\n7.2\n13.5–17.5\n\n\nMean corpuscular volume (μm3)\n104\n80–100\n\n\nPlatelet count (per mm3)\n40,000\n150,000–350,000\n\n\nTotal bilirubin (mg/dL)\n0.9\n0.3–1.0\n\n\nCreatinine (mg/dL)\n0.5\n0.8–1.3\n\n\nA bone-marrow aspirate and biopsy shows 90% cellularity with trilineage dysplasia. Myeloid blasts are not increased. Cytogenetic analysis reveals a monosomy 7 clone. Testing for pathogenic variants in the BCR-ABL, JAK2, CALR, and MPL genes is negative.\nWhich one of the following diagnoses is most likely in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Myelodysplastic syndrome"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 3,
          "text": "Aplastic anemia"
        },
        {
          "id": 4,
          "text": "Clonal hematopoiesis of indeterminant potential"
        },
        {
          "id": 5,
          "text": "Chronic myelomonocytic leukemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><h4 style='color: #34d399; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>A) CORRECT:</h4>The <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndromes</a> (<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>) are a heterogeneous group of clonal bone-marrow <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Za6c03f509be1b3d9dfdc8402fad24824\" data-learningcard-id=\"WM0Png\" data-anker=\"Za6c03f509be1b3d9dfdc8402fad24824\" data-section-id=\"azXQr00\" data-sememe-id=\"kXcmya0\">neoplasms</a> characterized by ineffective <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zaf3eea93f4a62b1b114e6d818763b6ea\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zaf3eea93f4a62b1b114e6d818763b6ea\" data-section-id=\"NDc-ee0\" data-sememe-id=\"6i0jsf\">hematopoiesis</a> and risk for progression to <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>. The diagnosis should be suspected in an older patient with <span data-sememe-id=\"_rX5Pz\">cytopenias</span> and can be confirmed by bone-marrow <span data-sememe-id=\"sebtZG\">biopsy</span>. In patients with <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a>, trilineage <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a>, <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Za42bd9559632f78627035ea098e277f8\" data-learningcard-id=\"y50d5g\" data-anker=\"Za42bd9559632f78627035ea098e277f8\" data-section-id=\"BWcznY0\" data-sememe-id=\"GNXBcA\">monosomy</a> 7, and a <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7b282304b96823a9cc8313be123b9fc9\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7b282304b96823a9cc8313be123b9fc9\" data-section-id=\"nac7Oa0\" data-sememe-id=\"ArXRPz\">myeloblast</a> count &lt;20%, the correct diagnosis is <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>. In <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>, the marrow <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7b282304b96823a9cc8313be123b9fc9\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7b282304b96823a9cc8313be123b9fc9\" data-section-id=\"nac7Oa0\" data-sememe-id=\"ArXRPz\">myeloblast</a> count is ≥20%.<br><br><span class=\"wichtig\"><b>Key learning point:</b></span> The findings of <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a>, bone-marrow <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a>, and a <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Za42bd9559632f78627035ea098e277f8\" data-learningcard-id=\"y50d5g\" data-anker=\"Za42bd9559632f78627035ea098e277f8\" data-section-id=\"BWcznY0\" data-sememe-id=\"GNXBcA\">monosomy</a> 7 clone on cytogenetic analysis establish a diagnosis of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>B) INCORRECT:</h4>In <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>, the marrow <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7b282304b96823a9cc8313be123b9fc9\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7b282304b96823a9cc8313be123b9fc9\" data-section-id=\"nac7Oa0\" data-sememe-id=\"ArXRPz\">myeloblast</a> count is ≥20%.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>C) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Z662f3d972a21d72555c5912a02f7b769\" data-learningcard-id=\"DF0143\" data-anker=\"Z662f3d972a21d72555c5912a02f7b769\" data-section-id=\"iQdJDp0\" data-sememe-id=\"Sr0ygh\">Aplastic anemia</a> is not typically associated with any <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z104e70d0abf334234d6d1c24c660d384\" data-learningcard-id=\"y50d5g\" data-anker=\"Z104e70d0abf334234d6d1c24c660d384\" data-section-id=\"xWcEnY0\" data-sememe-id=\"T0c62a0\">chromosome</a> abnormalities or with bone-marrow hypercellularity.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>D) INCORRECT:</h4>\n<span data-sememe-id=\"3FdS370\">Clonal hematopoiesis</span> of indeterminant potential (CHIP) is characterized by the presence of a clonal population of cells in the blood or <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zba672ce639f8a71189c3b29114401a54\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zba672ce639f8a71189c3b29114401a54\" data-section-id=\"NDc-ee0\" data-sememe-id=\"CYcqra0\">bone marrow</a> carrying a <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z071acae145ea72512f23c747393edb44\" data-learningcard-id=\"y50d5g\" data-anker=\"Z071acae145ea72512f23c747393edb44\" data-section-id=\"BWcznY0\" data-sememe-id=\"qCYCGr\">somatic mutation</a> but without associated features to meet diagnostic criteria for another hematologic <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z8c3bce39ca977e0f872b6d9fb3be8cfb\" data-learningcard-id=\"WM0Png\" data-anker=\"Z8c3bce39ca977e0f872b6d9fb3be8cfb\" data-section-id=\"azXQr00\" data-sememe-id=\"OHXIqz\">malignancy</a>. In this case, the presence of trilineage <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a> with a clonal mutation and <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a> fulfills the criteria for <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>E) INCORRECT:</h4>Chronic myelomonocytic <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemia</a> is a <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Za6c03f509be1b3d9dfdc8402fad24824\" data-learningcard-id=\"WM0Png\" data-anker=\"Za6c03f509be1b3d9dfdc8402fad24824\" data-section-id=\"azXQr00\" data-sememe-id=\"kXcmya0\">neoplasm</a> with both myelodysplastic and myeloproliferative features that presents with <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a> and a peripheral blood <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z7853b03fd8ea5a463742a73a2bfea6ba\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z7853b03fd8ea5a463742a73a2bfea6ba\" data-section-id=\"OU1IWT0\" data-sememe-id=\"8vbObD\">monocytosis</a> of at least 1000 per mm<sup>3</sup>. However, <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z7853b03fd8ea5a463742a73a2bfea6ba\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z7853b03fd8ea5a463742a73a2bfea6ba\" data-section-id=\"OU1IWT0\" data-sememe-id=\"8vbObD\">monocytosis</a> can also be seen in <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> without a diagnosis of chronic myelomonocytic <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemia</a>.</div>",
      "hint": "",
      "explanations": [],
      "difficulty": "3/5",
      "question_id": "VgYG8o",
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "An 81-year-old woman with dementia presents with increasing fatigue and weakness. The patient’s daughter, who serves as durable power of attorney, reports that her mother enjoys daily walks but recently has been too tired for this and other daily activities.\nOne year ago, the patient was diagnosed with low-risk myelodysplastic syndrome during a workup of unexplained mild macrocytic anemia. Her bone-marrow cytogenetic results were normal, and she has not required treatment for myelodysplastic syndrome to date.\nOn examination, she is using a walker and appears tired and frail. Her skin is clear but extremely pale, and she has trace bilateral pitting edema. Vital signs are normal apart from a heart rate of 100 beats per minute. Her heart rhythm is regular and tachycardic, and her lungs are clear. There is no jugular venous distention. Her abdomen is soft and without hepatosplenomegaly.\nLaboratory testing reveals the following results:\n\n\n\nPatient value\nReference range\n\n\nLeukocyte count (per mm3)\n4000\n4500–11,000\n\n\nHemoglobin (g/dL)\n8.8\n12.0–16.0\n\n\nMean corpuscular volume (μm3)\n100\n80–100\n\n\nPlatelet count (per mm3)\n130,000\n150,000–350,000\n\n\nSerum erythropoietin (IU/liter)\n25\n5–36\n\n\nCreatinine (mg/dL)\n0.4\n0.6–1.1\n\n\nThe patient’s daughter asks about treatments that might improve her mother’s quality of life, but she wishes to avoid red-cell transfusions because of religious preferences.\nWhich one of the following treatments is most appropriate for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Azacitidine"
        },
        {
          "id": 2,
          "text": "Erythropoietin"
        },
        {
          "id": 3,
          "text": "Lenalidomide"
        },
        {
          "id": 4,
          "text": "Granulocyte colony-stimulating factor"
        },
        {
          "id": 5,
          "text": "Antithymocyte globulin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>A) INCORRECT:</h4>Azacitidine is more frequently used in patients with higher-risk diseases or as an alternative option following failure or relapse after treatment with <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z1a2fb84f960b73f9ad83e6b7ca46f6b1\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z1a2fb84f960b73f9ad83e6b7ca46f6b1\" data-section-id=\"NDc-ee0\">hematopoietic growth factors</a>. This agent often has unacceptable toxicity in older patients.</div><div><h4 style='color: #34d399; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>B) CORRECT:</h4>In a patient with significant medical comorbidities, low-risk <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> (<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>), and <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a> symptoms that affect quality of life, <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusion</a> support would be a reasonable option. Her serum <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zd204f98f466243eef04001e3c76b1653\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zd204f98f466243eef04001e3c76b1653\" data-section-id=\"NDc-ee0\" data-sememe-id=\"O30Iif\">erythropoietin</a> (<span data-sememe-id=\"5dWiq40\">EPO</span>) level is inappropriately low for her degree of <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Zd40074de20e25de472779d74fcfd35af\" data-learningcard-id=\"6T0j72\" data-anker=\"Zd40074de20e25de472779d74fcfd35af\" data-sememe-id=\"KP0UfT\">anemia</a>. For patients who wish to avoid red-cell <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusions</a>, <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zd204f98f466243eef04001e3c76b1653\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zd204f98f466243eef04001e3c76b1653\" data-section-id=\"NDc-ee0\" data-sememe-id=\"O30Iif\">erythropoietin</a> (<span data-sememe-id=\"5dWiq40\">EPO</span>) can elicit a red-cell response rate in approximately 30% to 40% of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> patients, with higher rates in patients with low-risk disease, low serum <span data-sememe-id=\"5dWiq40\">EPO</span> levels, or lack of red-cell <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusion</a> dependence. Some formulations of <span data-sememe-id=\"5dWiq40\">EPO</span> contain human <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z9110b2994a3ccd57883efb00defab92b\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z9110b2994a3ccd57883efb00defab92b\" data-section-id=\"9acN5a0\" data-sememe-id=\"GmYBSp\">albumin</a> (up to 2.5 g), which may or may not be acceptable to the patient; alternative <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z9110b2994a3ccd57883efb00defab92b\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z9110b2994a3ccd57883efb00defab92b\" data-section-id=\"9acN5a0\" data-sememe-id=\"GmYBSp\">albumin</a>-free formulations are available for some <span data-sememe-id=\"1QW2EO0\">erythropoietin-stimulating agents</span>.<br><br><span class=\"wichtig\"><b>Key learning point:</b></span> The most appropriate first-line treatments for <a href=\"https://www.amboss.com/us/library#xid=6T0j72&anker=Za060d87eb8995c9dddd73b2c13d2749d\" data-learningcard-id=\"6T0j72\" data-anker=\"Za060d87eb8995c9dddd73b2c13d2749d\" data-section-id=\"bM0HMg\" data-sememe-id=\"8n1OEh0\">symptomatic anemia</a> in patients with low-risk <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a> are <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zd204f98f466243eef04001e3c76b1653\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zd204f98f466243eef04001e3c76b1653\" data-section-id=\"NDc-ee0\" data-sememe-id=\"O30Iif\">erythropoietin</a> and <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusion</a> support.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>C) INCORRECT:</h4>\n<span data-sememe-id=\"jLb_x8\">Lenalidomide</span> is the agent of choice for patients with the 5q minus subtype of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>. In these patients, the red-cell <a href=\"https://www.amboss.com/us/library#xid=2M0TLg&anker=Z0d767a500a4efcb1314a93ab2616de44\" data-learningcard-id=\"2M0TLg\" data-anker=\"Z0d767a500a4efcb1314a93ab2616de44\" data-sememe-id=\"jo0_bS\">transfusion</a> independence rate is almost 70% and the cytogenetic remission rate is nearly 50%. <span data-sememe-id=\"jLb_x8\">Lenalidomide</span> is less effective in other forms of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>D) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zfd36502a16721ffbb26ffb131823954e\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zfd36502a16721ffbb26ffb131823954e\" data-section-id=\"NDc-ee0\" data-sememe-id=\"3R0S5f\">Granulocyte colony-stimulating factor</a> (<a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zfd36502a16721ffbb26ffb131823954e\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zfd36502a16721ffbb26ffb131823954e\" data-section-id=\"NDc-ee0\" data-sememe-id=\"3R0S5f\">G-CSF</a>) is typically used for <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> patients with <a href=\"https://www.amboss.com/us/library#xid=KJ0UES&anker=Z02cca18dc80991f0022e19f9336e54ac\" data-learningcard-id=\"KJ0UES\" data-anker=\"Z02cca18dc80991f0022e19f9336e54ac\" data-sememe-id=\"CVYq9L\">febrile neutropenia</a>, or moderate-to-severe <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z772ef39ffb5b26ae57fce3aa721f12a9\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z772ef39ffb5b26ae57fce3aa721f12a9\" data-section-id=\"OU1IWT0\" data-sememe-id=\"wMbhI8\">neutropenia</a> and a history of recurrent infections. As a single agent, <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zfd36502a16721ffbb26ffb131823954e\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zfd36502a16721ffbb26ffb131823954e\" data-section-id=\"NDc-ee0\" data-sememe-id=\"3R0S5f\">G-CSF</a> does not improve <a href=\"https://www.amboss.com/us/library#xid=WS0PA2&anker=Z94b6c5cf373e3de2a4f32b9f3fb10b4e\" data-learningcard-id=\"WS0PA2\" data-anker=\"Z94b6c5cf373e3de2a4f32b9f3fb10b4e\" data-section-id=\"8JXOD_\" data-sememe-id=\"85bON8\">hemoglobin</a> levels. But in patients who fail to respond or relapse after <span data-sememe-id=\"5dWiq40\">EPO</span> monotherapy, adding <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zfd36502a16721ffbb26ffb131823954e\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zfd36502a16721ffbb26ffb131823954e\" data-section-id=\"NDc-ee0\" data-sememe-id=\"3R0S5f\">G-CSF</a> to <span data-sememe-id=\"5dWiq40\">EPO</span> may improve the red-cell response rate.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>E) INCORRECT:</h4>Antithymocyte globulin is more frequently used in patients with higher-risk diseases or as an alternative option following failure or relapse after treatment with <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z1a2fb84f960b73f9ad83e6b7ca46f6b1\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z1a2fb84f960b73f9ad83e6b7ca46f6b1\" data-section-id=\"NDc-ee0\">hematopoietic growth factors</a>. This agent often has unacceptable toxicity in older patients.</div>",
      "hint": "",
      "explanations": [],
      "difficulty": "3/5",
      "question_id": "egYx8o",
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "text": "A 75-year-old man reports a 4-month history of progressively worsening dyspnea, fatigue, and exercise intolerance. One week ago, he noticed unexplained bruising and had two episodes of epistaxis. On examination, the patient is afebrile, in no distress, and appears pale and tired. Pulse is 105/min, blood pressure is 110/70 mm Hg, and respirations are 18/min. He has normal oxygen saturation and his lungs are clear. His abdomen is soft without hepatosplenomegaly. He has several ecchymoses on his extremities and a petechial rash on his lower extremities, but no edema. Laboratory testing reveals these results:\n\n\nLeukocyte count\n2200/mm3\n\n\nNeutrophils\n1000/mm3\n\n\n\nMonocytes\n500/mm3\n\n\n\nHemoglobin\n7.2 g/dL\n\n\nMean corpuscular volume\n104/μm3\n\n\n\nPlatelet count\n40,000/mm3\n\n\nA bone-marrow aspirate and biopsy shows 90% cellularity with trilineage dysplasia. Myeloid blasts are not increased. Cytogenetic analysis reveals a monosomy 7 clone. Testing for pathogenic variants in the BCR-ABL, JAK2, CALR, and MPL genes is negative. Which one of the following diagnoses is most likely in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Myelodysplastic syndrome"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 3,
          "text": "Aplastic anemia"
        },
        {
          "id": 4,
          "text": "Clonal hematopoiesis of indeterminant potential"
        },
        {
          "id": 5,
          "text": "Chronic myelomonocytic leukemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div><h4 style='color: #34d399; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>A) CORRECT:</h4>The <span class=\"wichtig\"><b><a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndromes</a></b></span> (<a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>) are a heterogeneous group of clonal bone-marrow <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Za6c03f509be1b3d9dfdc8402fad24824\" data-learningcard-id=\"WM0Png\" data-anker=\"Za6c03f509be1b3d9dfdc8402fad24824\" data-section-id=\"azXQr00\" data-sememe-id=\"kXcmya0\">neoplasms</a> characterized by ineffective <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zaf3eea93f4a62b1b114e6d818763b6ea\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zaf3eea93f4a62b1b114e6d818763b6ea\" data-section-id=\"NDc-ee0\" data-sememe-id=\"6i0jsf\">hematopoiesis</a> and risk for progression to <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>. The diagnosis should be suspected in an <span class=\"wichtig\"><b>older patient with <span data-sememe-id=\"_rX5Pz\">cytopenias</span></b></span> and can be confirmed by bone-marrow <span data-sememe-id=\"sebtZG\">biopsy</span>. In patients with <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a>, trilineage <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a>, <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Za42bd9559632f78627035ea098e277f8\" data-learningcard-id=\"y50d5g\" data-anker=\"Za42bd9559632f78627035ea098e277f8\" data-section-id=\"BWcznY0\" data-sememe-id=\"GNXBcA\">monosomy</a> 7, and a <span class=\"wichtig\"><b><a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7b282304b96823a9cc8313be123b9fc9\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7b282304b96823a9cc8313be123b9fc9\" data-section-id=\"nac7Oa0\" data-sememe-id=\"ArXRPz\">myeloblast</a> count &lt;20%</b></span>, the correct diagnosis is <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>. In <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>, the marrow <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7b282304b96823a9cc8313be123b9fc9\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7b282304b96823a9cc8313be123b9fc9\" data-section-id=\"nac7Oa0\" data-sememe-id=\"ArXRPz\">myeloblast</a> count is ≥20%.<br><br><span class=\"wichtig\"><b>Key learning point:</b></span> The findings of <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a>, bone-marrow <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a>, and a <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Za42bd9559632f78627035ea098e277f8\" data-learningcard-id=\"y50d5g\" data-anker=\"Za42bd9559632f78627035ea098e277f8\" data-section-id=\"BWcznY0\" data-sememe-id=\"GNXBcA\">monosomy</a> 7 clone on cytogenetic analysis establish a diagnosis of <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">myelodysplastic syndrome</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>B) INCORRECT:</h4>In <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zdf106029b619b896fe5d8c0363d4258b\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zdf106029b619b896fe5d8c0363d4258b\" data-section-id=\"Hl0KyT\" data-sememe-id=\"fwbkRD\">acute myeloid leukemia</a>, the marrow <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Z7b282304b96823a9cc8313be123b9fc9\" data-learningcard-id=\"ln0vtg\" data-anker=\"Z7b282304b96823a9cc8313be123b9fc9\" data-section-id=\"nac7Oa0\" data-sememe-id=\"ArXRPz\">myeloblast</a> count is ≥20%.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>C) INCORRECT:</h4>\n<a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Z662f3d972a21d72555c5912a02f7b769\" data-learningcard-id=\"DF0143\" data-anker=\"Z662f3d972a21d72555c5912a02f7b769\" data-section-id=\"iQdJDp0\" data-sememe-id=\"Sr0ygh\">Aplastic anemia</a> is not typically associated with any <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z104e70d0abf334234d6d1c24c660d384\" data-learningcard-id=\"y50d5g\" data-anker=\"Z104e70d0abf334234d6d1c24c660d384\" data-section-id=\"xWcEnY0\" data-sememe-id=\"T0c62a0\">chromosome</a> abnormalities or with bone-marrow hypercellularity.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>D) INCORRECT:</h4>\n<span data-sememe-id=\"3FdS370\">Clonal hematopoiesis</span> of indeterminant potential (CHIP) is characterized by the presence of a clonal population of cells in the blood or <a href=\"https://www.amboss.com/us/library#xid=ln0vtg&anker=Zba672ce639f8a71189c3b29114401a54\" data-learningcard-id=\"ln0vtg\" data-anker=\"Zba672ce639f8a71189c3b29114401a54\" data-section-id=\"NDc-ee0\" data-sememe-id=\"CYcqra0\">bone marrow</a> carrying a <a href=\"https://www.amboss.com/us/library#xid=y50d5g&anker=Z071acae145ea72512f23c747393edb44\" data-learningcard-id=\"y50d5g\" data-anker=\"Z071acae145ea72512f23c747393edb44\" data-section-id=\"BWcznY0\" data-sememe-id=\"qCYCGr\">somatic mutation</a> but without associated features to meet diagnostic criteria for another hematologic <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z8c3bce39ca977e0f872b6d9fb3be8cfb\" data-learningcard-id=\"WM0Png\" data-anker=\"Z8c3bce39ca977e0f872b6d9fb3be8cfb\" data-section-id=\"azXQr00\" data-sememe-id=\"OHXIqz\">malignancy</a>. In this case, the presence of trilineage <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a> with a clonal mutation and <a href=\"https://www.amboss.com/us/library#xid=DF0143&anker=Ze01d92bb936cf77e9b537f904fd29a4b\" data-learningcard-id=\"DF0143\" data-anker=\"Ze01d92bb936cf77e9b537f904fd29a4b\" data-sememe-id=\"qg0Cw2\">pancytopenia</a> fulfills the criteria for <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a>.</div><div><h4 style='color: #f87171; font-weight: bold; margin-top: 16px; font-size: 1.125rem;'>E) INCORRECT:</h4>Chronic myelomonocytic <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemia</a> is a <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Za6c03f509be1b3d9dfdc8402fad24824\" data-learningcard-id=\"WM0Png\" data-anker=\"Za6c03f509be1b3d9dfdc8402fad24824\" data-section-id=\"azXQr00\" data-sememe-id=\"kXcmya0\">neoplasm</a> with both myelodysplastic and myeloproliferative features that presents with <a href=\"https://www.amboss.com/us/library#xid=WM0Png&anker=Z409fc6a3e32d11acbee6f0b5c89913e1\" data-learningcard-id=\"WM0Png\" data-anker=\"Z409fc6a3e32d11acbee6f0b5c89913e1\" data-section-id=\"azXQr00\" data-sememe-id=\"18a2lm\">dysplasia</a> and a peripheral blood <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z7853b03fd8ea5a463742a73a2bfea6ba\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z7853b03fd8ea5a463742a73a2bfea6ba\" data-section-id=\"OU1IWT0\" data-sememe-id=\"8vbObD\">monocytosis</a> of at least 1000 per mm<sup>3</sup>. However, <a href=\"https://www.amboss.com/us/library#xid=Ln0wFg&anker=Z7853b03fd8ea5a463742a73a2bfea6ba\" data-learningcard-id=\"Ln0wFg\" data-anker=\"Z7853b03fd8ea5a463742a73a2bfea6ba\" data-section-id=\"OU1IWT0\" data-sememe-id=\"8vbObD\">monocytosis</a> can also be seen in <a href=\"https://www.amboss.com/us/library#xid=3T0Sq2&anker=Zfda61924b603eb5304faf491e8ded93f\" data-learningcard-id=\"3T0Sq2\" data-anker=\"Zfda61924b603eb5304faf491e8ded93f\" data-sememe-id=\"PP0WUT\">MDS</a> without a diagnosis of chronic myelomonocytic <a href=\"https://www.amboss.com/us/library#xid=iT0Jq2&anker=Zc0da5e32087bb9fdebbaad4515b11425\" data-learningcard-id=\"iT0Jq2\" data-anker=\"Zc0da5e32087bb9fdebbaad4515b11425\" data-section-id=\"Hl0KyT\" data-sememe-id=\"vMbAq8\">leukemia</a>.</div>",
      "hint": "90% of these cases are idiopathic and most commonly manifest in older adults.",
      "explanations": [],
      "difficulty": "3/5",
      "question_id": "nUb7dG",
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}